(Q41085365)

English

A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia

scientific article published on January 1, 1979

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia (English)

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Peter H. Wiernik

1

object named as

Wiernik PH

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

DelDuca V

9

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

O. J. Glidewell

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

H. C. Hoagland

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

K. W. Brunner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

C. L. Spurr

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

J. Cuttner

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

R. T. Silver

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

R. W. Carey

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

V. DelDuca

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

F. H. Kung

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

J. F. Holland

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381887

14 April 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=381887

14 April 2023

publication date

1 January 1979

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmpo.2950060311

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/mpo.2950060311

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Medical and Pediatric Oncology

6

3

261–77

publication date

1979

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=381887

14 April 2023

6

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

261-277

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FMPO.2950060311

21 January 2018

Treatment of acute myeloid leukaemia with a triple cytotoxic regime: dat

1 reference

https://api.crossref.org/works/10.1002%2FMPO.2950060311

21 January 2018

Treatment of acute leukemia in adults

2

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous Leukaemia

3

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

4

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Potentiation of carcinostasis by combinations of thioguanine and 6-mercaptopurine

9

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Daunorubicin-prednisone remission induction with hydroxyurea maintenance in acute non-lymphocytic leukemia

10

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Some Methods for Strengthening the Common χ 2 Tests

12

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Cancer Treatment Reports

13

60

41

author name string

Wiernik

publication date

1976

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

British Journal of Cancer

18

28

375

author name string

Powles

publication date

1973

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).

19

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Prognosis in adult acute myelogenous leukemia related to performance status and other factors

20

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials

22

1 reference

10.1002/MPO.2950060311

https://api.crossref.org/works/10.1002/MPO.2950060311

14 April 2023

Identifiers

10.1002/MPO.2950060311

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41085365&oldid=1875054167"